Voho Anu, Metsola Katja, Anttila Sisko, Impivaara Olli, Järvisalo Jorma, Vainio Harri, Husgafvel-Pursiainen Kirsti, Hirvonen Ari
Finnish Institute of Occupational Health, Topeliuksenkatu 41 a A, FIN-00250 Helsinki, Finland.
Cancer Lett. 2006 Jun 8;237(1):102-8. doi: 10.1016/j.canlet.2005.05.029. Epub 2005 Jul 7.
We investigated the roles of EPHX1 Tyr113His and His139Arg polymorphisms in lung cancer susceptibility in a Finnish study population comprising of 230 lung cancer cases and a large control group (n=2105). The controls were distributed into five age strata, which enabled us to examine the potential age-related changes in the putative EPHX1 at-risk genotypes in the cancer free population. Although the exon 3 slow activity associated allele (His113) containing genotypes posed a decreased lung cancer risk compared with the homozygous wild-type Tyr113/Tyr113 genotype (OR, 0.68; 95% CI, 0.49-0.94), no association was seen for the EPHX1 phenotypes interpreted from the combined exons 3 and 4 genotype data. Neither was any difference seen in the prevalence of the EPHX1 Tyr113His genotypes or interpreted EPHX1 phenotypes in the different age groups.
在一项芬兰研究人群中,我们调查了EPHX1基因Tyr113His和His139Arg多态性在肺癌易感性中的作用。该研究人群包括230例肺癌病例和一个大型对照组(n = 2105)。对照组被分为五个年龄层,这使我们能够研究无癌人群中假定的EPHX1风险基因型潜在的年龄相关变化。尽管与纯合野生型Tyr113/Tyr113基因型相比,含有外显子3慢活性相关等位基因(His113)的基因型导致肺癌风险降低(OR,0.68;95% CI,0.49 - 0.94),但从外显子3和4的组合基因型数据解读的EPHX1表型未发现关联。在不同年龄组中,EPHX1 Tyr113His基因型或解读的EPHX1表型的患病率也没有差异。